The healthcare group says that the revenue decrease was due to reduced revenue from the Pharmaceutical and Medical Aesthetics segment and Digital Platform and E-pharmacy segment, which saw a decline in revenue of 18.9% and 5.9% y-o-y respectively.
Hyphens Pharma International has reported earnings of $1.9 million for the 1HFY2025 ended June 30, down 66.3% y-o-y.
Revenue for 1HFY2025 declined 10.1% y-o-y to $89.5 million, and profit before tax declined 61.3% y-o-y to $2.9 million.
